Kari Peersen

461 total citations
27 papers, 332 citations indexed

About

Kari Peersen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Kari Peersen has authored 27 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 6 papers in Economics and Econometrics. Recurrent topics in Kari Peersen's work include Lipoproteins and Cardiovascular Health (11 papers), Cardiac Health and Mental Health (11 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Kari Peersen is often cited by papers focused on Lipoproteins and Cardiovascular Health (11 papers), Cardiac Health and Mental Health (11 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Kari Peersen collaborates with scholars based in Norway, Sweden and Germany. Kari Peersen's co-authors include John Munkhaugen, Jan Erik Otterstad, Lars Gullestad, Toril Dammen, Torbjørn Moum, Joep Perk, Einar Husebye, Erik Gjertsen, Harald Arnesen and J. E. Otterstad and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Kari Peersen

25 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kari Peersen Norway	13	184	85	67	46	44	27	332
Roma Puronaitė Lithuania	12	190 1.0×	82 1.0×	92 1.4×	67 1.5×	33 0.8×	52	415
Alasdair Coutts United Kingdom	5	152 0.8×	52 0.6×	40 0.6×	56 1.2×	22 0.5×	6	358
Alaaeddin Alrohaibani United States	9	184 1.0×	48 0.6×	26 0.4×	21 0.5×	49 1.1×	18	365
Rimvydas Šlapikas Lithuania	11	178 1.0×	64 0.8×	55 0.8×	18 0.4×	21 0.5×	39	360
Merrill Thomas United States	10	158 0.9×	94 1.1×	14 0.2×	26 0.6×	33 0.8×	27	292
Marcin Rutkowski Poland	10	147 0.8×	52 0.6×	39 0.6×	23 0.5×	25 0.6×	23	382
Ellis Lader United States	9	281 1.5×	53 0.6×	22 0.3×	30 0.7×	56 1.3×	19	387
André Zimerman United States	10	222 1.2×	107 1.3×	31 0.5×	19 0.4×	14 0.3×	41	398
Jian Bo China	9	155 0.8×	30 0.4×	38 0.6×	21 0.5×	13 0.3×	14	342
K. A. Pearce United States	12	146 0.8×	55 0.6×	42 0.6×	8 0.2×	40 0.9×	20	346

Countries citing papers authored by Kari Peersen

Since Specialization

Citations

This map shows the geographic impact of Kari Peersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Peersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Peersen more than expected).

Fields of papers citing papers by Kari Peersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Peersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Peersen. The network helps show where Kari Peersen may publish in the future.

Co-authorship network of co-authors of Kari Peersen

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Peersen. A scholar is included among the top collaborators of Kari Peersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Peersen. Kari Peersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Munkhaugen, John, et al.. (2024). Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease. Clinical and Translational Science. 17(10). e70025–e70025. 1 indexed citations

Munkhaugen, John, Stein Bergan, Kari Peersen, et al.. (2024). The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study. SHILAP Revista de lepidopterología. 55. 31–38. 2 indexed citations

Munkhaugen, John, et al.. (2023). Atorvastatin lactone/acid ratios are promising biomarkers for statin dependent muscular side effects in patients with coronary heart disease. European Journal of Preventive Cardiology. 30(Supplement_1).

Munkhaugen, John, Harald Weedon‐Fekjær, Kari Peersen, et al.. (2023). Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease. Pharmacology Research & Perspectives. 11(3). e01089–e01089. 2 indexed citations

Munkhaugen, John, Kari Peersen, Anders Andersen, et al.. (2023). Atorvastatin Metabolite Pattern in Skeletal Muscle and Blood from Patients with Coronary Heart Disease and Statin‐Associated Muscle Symptoms. Clinical Pharmacology & Therapeutics. 113(4). 887–895. 6 indexed citations

Peersen, Kari, Morten Wang Fagerland, Erik Gjertsen, et al.. (2021). The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease. Atherosclerosis. 336. 23–29. 2 indexed citations

Vethe, Nils Tore, Kari Peersen, Morten Wang Fagerland, et al.. (2020). Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial. European Heart Journal - Cardiovascular Pharmacotherapy. 7(6). 507–516. 19 indexed citations

Peersen, Kari, Harald Weedon‐Fekjær, Joep Perk, et al.. (2020). Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population. BMC Cardiovascular Disorders. 20(1). 61–61. 15 indexed citations

Munkhaugen, John, et al.. (2020). Is the novel LDL-cholesterol goal <1.4 mmol/L achievable without a PCSK9 inhibitor in a chronic coronary population from clinical practice?. European Journal of Preventive Cardiology. 28(8). e10–e11. 6 indexed citations

10.

Peersen, Kari, Jan Erik Otterstad, Joep Perk, et al.. (2019). Medical and Psychosocial Factors Associated With Low Physical Activity and Increasing Exercise Level After a Coronary Event. Journal of Cardiopulmonary Rehabilitation and Prevention. 40(1). 35–40. 12 indexed citations

11.

Peersen, Kari, Jan Erik Otterstad, Lars Gullestad, et al.. (2017). Optimal blood pressure control after coronary events: the challenge remains. Journal of the American Society of Hypertension. 11(12). 823–830. 6 indexed citations

12.

Peersen, Kari, John Munkhaugen, Lars Gullestad, et al.. (2017). The role of cardiac rehabilitation in secondary prevention after coronary events. European Journal of Preventive Cardiology. 24(13). 1360–1368. 33 indexed citations

13.

Peersen, Kari, Einar Husebye, Erik Gjertsen, et al.. (2017). Unfavourable risk factor control after coronary events in routine clinical practice. BMC Cardiovascular Disorders. 17(1). 40–40. 23 indexed citations

14.

Peersen, Kari, John Munkhaugen, Lars Gullestad, et al.. (2017). Reproducibility of an extensive self-report questionnaire used in secondary coronary prevention. Scandinavian Journal of Public Health. 45(3). 269–276. 20 indexed citations

15.

Wahl, Astrid Klopstad, Richard H. Osborne, Eva Langeland, et al.. (2016). Making robust decisions about the impact of health education programs: Psychometric evaluation of the Health Education Impact Questionnaire (heiQ) in diverse patient groups in Norway. Patient Education and Counseling. 99(10). 1733–1738. 17 indexed citations

16.

Munkhaugen, John, Kari Peersen, Erik Gjertsen, et al.. (2016). Patient characteristics and risk factors of participants and non-participants in the NOR-COR study. Scandinavian Cardiovascular Journal. 50(5-6). 317–322. 6 indexed citations

17.

Munkhaugen, John, Kari Peersen, Erik Gjertsen, et al.. (2015). The role of medical and psychosocial factors for unfavourable coronary risk factor control. Scandinavian Cardiovascular Journal. 50(1). 1–8. 23 indexed citations

18.

Møller, Thomas, Henrik Brun, Per Morten Fredriksen, et al.. (2010). Right Ventricular Systolic Pressure Response During Exercise in Adolescents Born With Atrial or Ventricular Septal Defect. The American Journal of Cardiology. 105(11). 1610–1616. 37 indexed citations

19.

Møller, Thomas, Kari Peersen, Eirik Pettersen, et al.. (2009). Non-invasive measurement of the response of right ventricular pressure to exercise, and its relation to aerobic capacity. Cardiology in the Young. 19(5). 465–473. 13 indexed citations

20.

Peersen, Kari, et al.. (2006). Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease. European Journal of Cardiovascular Prevention & Rehabilitation. 13(3). 356–362. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact